CVS Health, Walmart and Walgreens Played Role in Opioid Crisis: Ohio Jury
THURSDAY, Nov. 24, 2021 (HealthDay News) -- CVS Health, Walmart and Walgreens contributed to opioid overdoses and deaths in two Ohio counties, a federal jury in Cleveland found Tuesday.
The first jury verdict in an opioids case came in the closely watched test case and may prove encouraging to plaintiffs in thousands of lawsuits across the United States using the same legal strategy -- that the companies contributed to a "public nuisance," The New York Times reported.
That argument was rejected this month by judges in California and Oklahoma in cases against opioid manufacturers.
The Ohio case is the first time the retail side of the drug industry has been held accountable in the U.S. opioid crisis, the Times reported. CVS Health, Walmart and Walgreens are three of the nation's largest pharmacy chains.
Following the verdict, the trial judge will decide how much each of the pharmacy chains will have to pay Lake and Trumbull counties in northeastern Ohio, the Times reported.
The counties' lawyers said the three companies turned a blind eye to suspicious opioid orders for years. Eventual oversight requirements were "too little, too late," said Mark Lanier, the counties' lead trial lawyer, the Times reported.
Overdose deaths from illegal opioids have reached record levels during the COVID-19 pandemic, new U.S. government data show, the Times reported.
More information
Visit the National Institute of Drug Abuse for more on opioids.
Related Posts
Drug Used to Prevent Miscarriage May Raise Lifetime Cancer Risk in Offspring
MONDAY, Nov. 15, 2021 (HealthDay News) -- People who were exposed to a...
Herbal Remedies & You: 6 Tips to Safeguard Your Health
WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- Not all prescription drugs and...
Another Study Finds Vaccine Booster ‘Neutralizes’ Omicron
THURSDAY, Jan. 20, 2022 (HealthDay News) -- If you need more proof that a third...
Effect of HF-Spinal Cord Stimulation on Chronic Pain Varies by Sex
TUESDAY, May 3, 2022 (HealthDay News) -- High-frequency spinal cord stimulation...